Any time insiders put their money where their mouths are, pay close attention.
Look at Nike (NKE).
Over the last few days, we learned that CEO Elliott Hill bought 16,400 shares for about $1 million. This follows news that Apple’s Tim Cook bought $3 million worth of Nike stock. Robert Swan, a Nike director, bought about $500,000 of stock on Dec. 22 at an average price of $57.54.
Since then, the oversold stock bounced from a low of $56.99 to $63.71. From here, we’d like to see NKE initially refill its bearish gap at $66.
Or, look at DoorDash (DASH).
In late November, board member Alfred Lin bought over $100 million worth of DASH. That’s massive skin in the game. You’re not likely to find someone spending that kind of money unless they have a good idea of progress and the opportunity for growth. Analysts at Needham also have a buy rating on the stock.
In addition, as noted by Seeking Alpha, “DoorDash management signaled 2026 as a transformational year, with major investments planned in a unified global tech platform, autonomous delivery, and new product launches such as DashMart Fulfillment Services. The company highlighted continued strength in its core and international businesses, improving unit economics, and a disciplined approach to large-scale investments.”
Or, take a look at Immunome Inc. (IMNM).
Over the last few days, President and CEO Clay Siegall bought 4,729 shares of INMN for just over $100,000.
Helping, the company recently posted statistically significant phase 3 RINGSIDE results for varegacestat in progressive desmoid tumors, achieving an 84% risk reduction in progression or death compared to placebo. Plus, as noted by Seeking Alpha, “Varegacestat demonstrated a 56% objective response rate, the highest ever in a randomized desmoid tumor trial, and a marked reduction in tumor volume.”
In addition, analysts at Guggenheim reiterated its Buy rating for Immunome, maintaining a price target of $35, following a $400 million financing announcement.
Today's Bonus Content: Investors Can’t Afford to Miss This
To carry out Trump's Executive Order #14196 initiative, the administration will have to partner with a handful of U.S. companies that control the reserve accounts sitting on trillions of dollars' worth of untapped natural resources. I've spent months digging into this – and I've identified three companies that have already been granted emergency status and fast-track approvals. I believe their shares could skyrocket once new capital starts moving into the sector.
See the three stocks that I expect to be the biggest winners as this plan rolls
Found this helpful? Share it with others.
Written by Ian Cooper